Search Results 1801-1810 of 4043 for Solid
Transplant. Mayo Clinic is the largest integrated transplant provider in the United States, performing all solid organ and bone marrow transplants.
... Solid Tumors [RECIST] Criteria), somatostatin receptor positive, well-differentiated neuroendocrine tumours of the small bowel (midgut carcinoid tumours).
Patients must not have undergone prior allogeneic bone marrow transplantation or prior solid organ transplantation; Patient must not have active tuberculosis ...
Has had an allogeneic tissue/solid organ transplant. Has received a live vaccine within 30 days prior to the first dose of trial treatment. Examples of live ...
... Solid Tumors 1.1 (RECIST 1.1) guidelines; Life expectancy ≥ 16 weeks from randomization; No prior cytotoxic chemotherapy for metastatic breast cancer. Prior ...
All extracranial disease must be assessed and documented on the Baseline Tumor Assessment Form (Response Evaluation Criteria in Solid Tumors [RECIST] 1.1).
A Study of the Safety, Tolerability, Drug/Body Interactions, Biological and Clinical Activity of MSB0011359C (M7824) in Metastatic or Locally Advanced Solid ...
Solid organ transplant patients are at higher risk of ...
... Solid Tumors (RECIST) 1.1, defined as at least one lesion that can be accurately measured in at least one dimension (longest diameter to be recorded) as ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!